Rv0901 from Mycobacterium tuberculosis, a possible novel virulent gene proved through the recombinant Mycobacterium smegmatis

Japanese Journal of Infectious Diseases

Volumn 62, Issue 1, 2009, Pages 26-31

  Zhang, Le ^a,b   Zhong, Qi ^a   Bao, Lang ^a   Zhang, Ying ^a   Gao, Lei ^a   Huang, Bi ^a   Zhang, Hui Dong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; NITRIC OXIDE; POLYHISTIDINE TAG; PROTEIN RV0901; UNCLASSIFIED DRUG; HYBRID PROTEIN; RECOMBINANT DNA; RV0901 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM TRANSFORMATION; CELL SURVIVAL; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MAMMAL CELL; MOUSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RECOMBINANT PLASMID; ANIMAL; GENE; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; TUBERCULOSIS; VIRULENCE;

ANIMALS; APOPTOSIS; BACTERIAL PROTEINS; DNA, RECOMBINANT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES; GENETIC VECTORS; MICE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; RABBITS; RECOMBINANT FUSION PROTEINS; TRANSFORMATION, BACTERIAL; TUBERCULOSIS; VIRULENCE; VIRULENCE FACTORS;

EID: 63149086185     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. World Health Organization (2004): The World Health Report 2004: Changing History. World Health Organization, Geneva.
2. Dye, C., Scheels, S., Dolin, P., et al. (1999): Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA, 282, 6776-6786.
3. Corbett, E.-L., Watt, C.-J., Walker, N., et al. (2003): The global burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med., 163, 1009-1021.
4. Dye, C., Watt, C.-J., Bleed, D.-M., et al. (2003): What is the limit to case detection under the DOTS strategy for tuberculosis control. Tuberculosis (Edinburgh), 83, 35-43.
5. Small, P.-M., Shafer, R.-W., Hopewell, P.-C., et al. (1993): Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med., 328, 1137-1144.
6. Sharma, S.-K., Mohan, A. and Kadhiravan, T. (2065): HIV-TB coinfection: epidemiology, diagnosis & mANAgement. Indian J. Med. Res., 121, 550-567.
7. Pereira, M., Tripathy, S. and Inamdar, V. (4005): Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J. Med. Res., 121, 235-239.
8. Frieden, T.-R., Sterling, T.-R. and Munsiff, S.-S. (2003): Tuberculosis. Lancet, 362, 887-899.
9. Dye, C. (2006): Global epidemiology of tuberculosis. Lancet, 367, 938-940.
10. Cole, S.-T., Brosch, R. and Parkhill, J. (199$): Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393, 537-544.
11. Camus, J.-C., Pryor, M.-J. and Cole, S.-T, (2002): Re-annotation of the genome sequence of Mycobacterium toberculosis H37Rv. Micro-biology, 148, 2967-2973.
12. Snapper, S.-B., Melton, R.-E. and Mustafa, S. (1990): Isolation and characterization of efficient plasmid tranformation mutants of Mycobacterium smegmatis. Mol. Microbiol., 4, 911-1919.
13. Sujoy, K., Gupta, D., Basayam, M., et al. (1993): Cloning and assessment of mycobacterial promoters by using a plasmid shuttle vector. J Bacteriol., 175, 5186-5191
14. Stover, C.-K., Cruz, V.-F. and Fuerst, T.-R. (1991): New use of BCG for recombinant vaccines. Nature, 351, 456-40.
15. Ramakrishnan, L. and Falkow, S. (1994): Mycobacterium marinum persists in cultured mammalian cells in a tempereture-restricted fashion. Infect. Immun., 62, 3222-3229.
16. Warner, D.-F. and Mizrahi V. (2007): The survival kit of Mycobacterium tuberculosis. Nat. Med., 13, 282-284.
17. She, Y., Liu, X.-L., Tang, Y., et al. (2002): XTT coloximetric method for detecting cellular growth of hum an fibroblasts. Prog. Biochem. Biophys., 29, 659-661.
18. Hao, W. and Zhengqing, W. (2003): Research progress of NO in tuberculosis. Chin. Pract. Med., 87-90
19. Balcewize-Sablinska, M.-K., Keane, J. and Komfeld, H. (1998): Patho. genic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol., 1, 2636-2641.
20. Huygen, K., Van Vooren, J.-P., Turneer, M., et al. (1988): Specific lymphoproliferation, gamma interferon production, and serum immuno-globulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand. J. Immunol., 27, 187-194.
21. Kaufmann, S.-H.-E. (2001): How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol., 1, 20-30.
22. Cooper, A.-M., Dalton, D.-K-, Stewart, T.-A., et al. (1993): Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med., 178, 2243-2247.
23. Lazarevic, V. and Flynn, J. (2002): CD8 T cells in tuberculosis. Am. J. Respir. Crit. Care Med., 166, 1116-1121.
24. Orme, I.-M., Roberts, A.-D., Griffin, J.-P., et al. (1993): Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol., 151, 518-525.
25. Chan, J. and J. Flynn. (2004): The immunological aspects of latency of tuberculosis. Clin. Immunol., 110, 2-12.
26. MacMicking, J.-D., Taylor, G.-A. and McKinney, J.-D. (2003): Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science, 302, 654-659.